阿尔特南作为一种具有多种应用的葡萄糖:属性,制备和健康功效
Yang Liu1, Jushuang Qin1, Imran Mahmood Khan2
1College of Food and Health, Zhejiang Agriculture and Forest University, Hangzhou 311300, China.
Food chemistry
|June 18, 2025
概括
阿尔特南是一种来自乳酸细菌的细胞外葡萄糖,为各种应用提供独特的特性. 这篇评论详细介绍了其结构,生产,修改以及在食品,药物和化品中的潜力.
科学领域:
- 生物化学和食品科学 生物化学和食品科学
- 微生物的多糖类
- 生物材料是一种生物材料.
背景情况:
- 阿尔特南是一种乳酸细菌产生的细胞外α-D葡萄糖.
- 它的特征是交替的α-(1→6) 和α-(1→3) 糖键.
- 对阿尔特南的特性和应用的研究正在扩大.
研究的目的:
- 综合总结交替研究的进展情况.
- 分析分子特征,物理化学性质和生产方法.
- 审查Alternan在各个领域的应用和商业潜力.
主要方法:
- 系统审查现有文献的替换.
- 对分子结构,链接组件和合物行为进行分析.
- 评估生产 (发酵,酶工程) 和修改技术 (酶,超声波).
主要成果:
- 阿尔特南表现出独特的合物行为,纳米粒子/薄膜形成,以及热稳定性.
- 它具有益生菌和乳化特性.
- 修改的替代品可以开发用于新型商业产品.
结论:
- 阿尔特南在食品,医药,医疗保健和化品行业具有重大潜力.
- 进一步的研究可以解锁扩展的应用和商业化.
- 了解其特性是开发新生物技术产品的关键.
相关概念视频
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Overview of Fungi
Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Ascomycota
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


